Joshua M. BennettJoshua M.Bennett

The Irvine Company in a large real estate domestic arbitration.

bluebird bio, a leading biotechnology company, in multiple federal district court and arbitration proceedings concerning cutting-edge gene therapy technology, defeating claims of more than $2 billion brought by San Rocco Therapeutics.

Third Rock Ventures in various commercial disputes.

Mitsubishi Tanabe in a multi-billion-dollar patent licensing dispute before the ICC, where our team obtained a final award rejecting every challenge by our adversaries, as well as $22 million in costs.

Otsuka in a complex licensing dispute simultaneously litigated in New York Supreme, the English High Court, and the ICDR arbitration, which were successfully settled.

The inventor of Trodelvy®, in a pending contractual dispute in Delaware Chancery against his former company.

Kratos in multiple litigation and arbitration matters, including a successfully resolved post-acquisition purchase price adjustment dispute in Delaware Chancery.

Genoptix in multiple matters, including an AAA arbitration where we obtained a final award of 100% of the amount in controversy in a complex medical billing dispute concerning approximately 15,000 medical procedures, preauthorization rules, and medical necessity.

Evrythng Ltd. in a complex trade secret dispute in the Southern District of New York.

A leading contract research organization in an AAA proceeding involving contract and fraud claims relating to the management of global oncology drug trial. After a 50-day hearing, the arbitrator issued a final award denying virtually all of our adversary’s allegations and awarding them approximately only 0.2% of the amount sought.

Lehman Brothers in multiple state, federal and arbitration proceedings, including a successful appeal before the New York Supreme Court, Appellate Division, First Department, concerning the enforceability of an arbitration provision in a limited partnership agreement governing the management of offshore funds, and various successfully-resolved adversary proceedings before the United States Bankruptcy Court for the Southern District of New York.

Barclays, as Appellee, before the United States Court of Appeals, Second Circuit, obtaining an affirmation of the complete dismissal with prejudice of numerous claims and alleged damages in excess of $1.25 billion, in connection with the sale of an entity that owned a submarine fiber optic cable network in the Caribbean.

Wolters Kluwer, in a four-week bench trial concerning an “exclusivity” provision between parties in merger negotiations, where we successfully obtained a plaintiff’s verdict.

The CEO of Gen Re, in one of the largest criminal investigations of the reinsurance industry. After seven years of litigation against the DOJ, SEC, and various class action plaintiff’s firms, the defense team successfully obtained dismissal of all criminal charges, dismissal or settlement of all civil claims, and a settlement with the SEC without any financial penalty imposed.